Pharmaceuticals

Valeant on Verge of Hiring Perrigo’s CEO?

Recipharm Buys Three Kemwell Businesses

Valeant CEO Agrees to Senate Deposition

GSK and Miltenyi Biotec in Cell and Gene Therapy Pact

Restrictions on Drug Trials Proposed After French Death

Ipsen Pays $855 Million for Exelixis’ Cancer Drug

UAE Scores with International Drugmakers

GSK Chief Says UK “Better in EU”

Global Data Sees Indian Generics Soaring

Dr. Wolff Licenses Tripeptide to China’s Link Health

Shire to Acquire Baxalta for $32 Billion

Teva and Takeda in Japanese Generics JV

Pfizer to Buy Allergan for $160 Billion

Eli Lilly Expands R&D at Indianapolis

Shire to Buy Biotech Firm Dyax

Evonik Starts Expanded Silica Plant in Japan

Pfizer and Allergan in Merger Talks

Overcoming USA Sales Resistance

Codexis Seals Wave 1 of Technology Transfer to US Merck

Drugmakers Launch UK Dementia Fund

Lilly Discontinues Potential Blockbuster

Merck-Pfizer Avelumab on FDA Fast Track

Easy Access for Customers

Pharma Players Mostly Lift 2015 Guidance

US Now Top Market for German Chemicals

Oxea in Detailed Engineering for US Propanol Unit

Germany-based Oxea has begun detailed engineering on its new propanol plant at Bay City, Texas, in the US, which is scheduled to go on stream at the end of 2017.

Clariant to Buy Part of Vivimed Portfolio

Johnson Matthey Acquires Pharmorphix

Envigo Officially Starts Under New Name

Caldic Completes Takeover of R2 Group

Merck and Pfizer Get FDA Orphan Drug Status

Merck to Close on Sigma-Aldrich in Q4

EU Commissions Backs New GSK Asthma Drug

Corbion Purac Takes Lactic Acid Business of Malladi Specialties

Bayer Realigns After Covestro Split